Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Wells Fargo analyst Stephen Baxter maintains Agilon Health (NYSE:AGL) with a Overweight and lowers the price target from $5 ...
Bernstein analyst Lance Wilkes downgrades Agilon Health (NYSE:AGL) from Outperform to Market Perform and lowers the price ta...
Jefferies analyst Jack Slevin maintains Agilon Health (NYSE:AGL) with a Hold and lowers the price target from $2.4 to $1.1.
Benchmark analyst Bill Sutherland maintains Agilon Health (NYSE:AGL) with a Buy and lowers the price target from $4 to $1.5.
Barclays analyst Andrew Mok maintains Agilon Health (NYSE:AGL) with a Underweight and lowers the price target from $3 to $1.5.
Citigroup analyst Daniel Grosslight downgrades Agilon Health (NYSE:AGL) from Buy to Neutral and lowers the price target from...
